Published in J Gen Microbiol on August 01, 1969
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology (1987) 7.92
A very small porcine virus with circular single-stranded DNA. Nature (1982) 4.35
Structure of simian virus 40. II. Symmetry and components of the virus particle. Virology (1967) 2.62
Structure of simian virus 40. 3. Alkaline degradation of the virus particle. Virology (1968) 2.58
Structure of simian virus 40. I. Purification and physical characterization of the virus particle. Virology (1967) 2.21
White matter asymmetry in the human brain: a diffusion tensor MRI study. Cereb Cortex (2004) 2.19
Influence of tissue conductivity anisotropy on EEG/MEG field and return current computation in a realistic head model: a simulation and visualization study using high-resolution finite element modeling. Neuroimage (2005) 1.74
Studies on mouse leukemia viruses. I. Isolation and characterization of a group-specific antigen. Virology (1969) 1.63
Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. Am J Surg (1978) 1.47
The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol (1991) 1.42
Otitis media in early childhood and its relationship to later phonological development. J Speech Hear Disord (1988) 1.40
LAV/HTLV-III in 20-week fetus. Lancet (1985) 1.40
A randomized controlled trial of smoking cessation intervention in pregnancy in an academic clinic. Obstet Gynecol (1996) 1.22
A comparison of neonatal mortality risk prediction models in very low birth weight infants. Pediatrics (2000) 1.21
Extensive chloroplast haplotype variation indicates Pleistocene hybridization and radiation of North American Arabis drummondii, A. x divaricarpa, and A. holboellii (Brassicaceae). Mol Ecol (2004) 1.19
Carcinoembryonic antigen follow-up and selection of patients for second-look operation in management of gastrointestinal carcinoma. J Surg Oncol (1978) 1.15
Isolation of cyclic inositol-1,2-phosphate from mammalian cells and a probable function of phosphatidylinositol turnover. Biochem Biophys Res Commun (1974) 1.14
Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer. Br J Cancer (1982) 1.14
Casein kinase II accumulation in the nucleolus and its role in nucleolar phosphorylation. Biochim Biophys Acta (1988) 1.14
Structure of simian virus 40. V. Localization of the C-type polypeptide chains. Virology (1971) 1.12
The formation of sphingomyelin from phosphatidylcholine in plasma membrane preparations from mouse fibroblasts. Biochim Biophys Acta (1981) 1.11
Low prevalence of HIV and other selected sexually transmitted infections in 2004 in pregnant women from Kinshasa, the Democratic Republic of the Congo. Epidemiol Infect (2007) 1.10
Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. Am J Surg (1985) 1.09
Rhodanine: a selective inhibitor of the multiplication of echovirus 12. Science (1970) 1.03
HTLV-III infection in kidney transplant recipients. Lancet (1985) 1.03
The role of endogenous phosphatidylcholine and ceramide in the biosynthesis of sphingomyelin in mouse fibroblasts. Biochim Biophys Acta (1982) 1.01
[Intestinal spirochetosis in HIV infection: prevalence, isolation and morphology of spirochetes]. Dtsch Med Wochenschr (1990) 1.00
Evidence for a new biosynthetic pathway of sphingomyelin in SV 40 transformed mouse cells. Biochem Biophys Res Commun (1972) 0.96
Are circulating CEA immune complexes a prognostic marker in patients with carcinoma of the gastrointestinal tract? Br J Cancer (1980) 0.96
Anti-(transforming growth factor beta) antibodies with predefined specificity inhibit metastasis of highly tumorigenic human xenotransplants in nu/nu mice. Cancer Immunol Immunother (1995) 0.95
Localization of phosphoprotein PP 105 in cell lines of various species. Biochem Biophys Res Commun (1983) 0.94
A difference in the breakdown of phosphatidylinositol in normal and SV40 transformed mouse fibroblasts. Biochem Biophys Res Commun (1973) 0.92
Changes in the spectrum of AIDS-defining conditions and decrease in CD4+ lymphocyte counts at AIDS manifestation in Germany from 1986 to 1991. AIDS (1992) 0.92
Stimulation of DNA polymerase alpha by a nuclear DNA/protein complex. J Supramol Struct Cell Biochem (1981) 0.92
Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma. Br J Cancer (1981) 0.92
Multiple phosphorylation of human SS-B/LA autoantigen and its effect on poly(U) and autoantibody binding. Biochim Biophys Acta (1987) 0.90
Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer. Br J Cancer (1982) 0.90
Immunodetection of nitrocellulose-adhesive proteins at the nanogram level after trinitrophenyl modification. Anal Biochem (1985) 0.89
Circulating carcinoembryonic antigen immune complexes in sera of patients with carcinomata of the gastrointestinal tract. Clin Exp Immunol (1979) 0.89
[Further studies on amino acid sequence of proteins in tobacco mosaic virus]. Z Naturforsch B (1965) 0.89
Treatment refusal/attrition among adults randomly assigned to programs at a drug treatment campus: The New Jersey Substance Abuse Treatment Campus, Seacaucus, NJ. J Subst Abuse Treat (2000) 0.88
Alternative pathways in the biosynthesis of sphingomyelin and the role of phosphatidylcholine, CDPcholine and phosphorylcholine as precursors. Hoppe Seylers Z Physiol Chem (1974) 0.88
Characterisation of nucleolar proteins as autoantigens using human autoimmune sera. Ann Rheum Dis (1986) 0.87
Cross-reactions of antisera against the terminal amino acid and dipeptide of tobacco mosaic virus. Biochim Biophys Acta (1966) 0.87
A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducer. Cancer Immunol Immunother (1990) 0.87
Antigenic properties of proteins cross-linked by multidiazonium compounds. Immunochemistry (1969) 0.87
Primary hepatocellular carcinoma in pregnancy. A case report. S Afr Med J (1986) 0.86
Isolation and characterization of phosphoprotein pp 105 from simian virus 40-transformed mouse fibroblasts. Biochim Biophys Acta (1983) 0.86
Phosphoprotein pp135 is an essential component of the nucleolus organizer region (NOR). Exp Cell Res (1986) 0.86
Alternative pathways in the biosynthesis of phosphatidylserine in mouse cells,. Hoppe Seylers Z Physiol Chem (1974) 0.85
Glycolipids of mouse fibroblasts and virus transformed mouse cell lines. Hoppe Seylers Z Physiol Chem (1972) 0.85
Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis. Cancer Immunol Immunother (1993) 0.85
Structure of simian virus 40. IV. The polypeptide chains of the virus particle. Virology (1968) 0.84
Immunogenicity of tumour cells modified with various chemicals. Br J Cancer (1977) 0.84
Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognition. Cancer Res (1990) 0.84
Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer. J Surg Oncol (1985) 0.83
Differences in the metabolism of phospholipids depending on cell population density. Biochem Biophys Res Commun (1973) 0.83
Mutants of the simian virus 40 which differ in cell-transforming activity. Nature (1967) 0.83
Specificity and sensitivity of anti-HTLV-III/LAV determinations with a recombinant antigen competitive ELISA. Infection (1987) 0.83
In vivo induction of neoplastic growth in nude mouse connective tissue adjacent to xenografted human tumors. J Cancer Res Clin Oncol (1983) 0.83
Isolation and localization of phosphoprotein pp 135 in the nucleoli of various cell lines. Eur J Biochem (1984) 0.83
The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies. Klin Wochenschr (1985) 0.82
Growth of human colonic adenocarcinoma and development of serum CEA in in athymic mice. I: Strict correlation of tumour size and mass with serum CEA concentration during logarithmic growth. Br J Cancer (1982) 0.82
Anti-epidermal growth factor receptor monoclonal antibodies affecting signal transduction. J Cell Biochem (1993) 0.82
Language skills of children with different preschool experiences. J Speech Hear Res (1989) 0.82
Activation of natural killer cell cytotoxicity of human blood monocytes by a low molecular weight component from viscum album extract. Arzneimittelforschung (1989) 0.81
[The doubling time of circulating CEA as an individual prognostic criterion of recurrence in patients with gastrointestinal cancers]. Klin Wochenschr (1986) 0.81
Kinetics of incorporation of ( 32 P)phosphate into phospholipids of a SV 40 transformed mouse cell during logarithmic growth. Hoppe Seylers Z Physiol Chem (1972) 0.81
Cell adhesion-dependent differences in endogenous protein phosphorylation on the surface of various cell lines. Biochim Biophys Acta (1981) 0.81
Circulating carcinoembryonic antigen (CEA), a growth parameter in malignant disease. Cancer Detect Prev (1983) 0.81
Biosynthesis of sphingomyelin. Transfer of phosphorylcholine from phosphatidylcholine to erythro-ceramide in a cell-free system. Hoppe Seylers Z Physiol Chem (1973) 0.81
Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicity. Immunopharmacology (1989) 0.80
Chemical studies on kallikrein inactivator from bovine lung and parotid gland. Ann N Y Acad Sci (1968) 0.80
Comparative studies of lipid content and lipid metabolism of normal and transformed mouse cells. Hoppe Seylers Z Physiol Chem (1972) 0.80
Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer. Oncodev Biol Med (1980) 0.80
Mediation of human NK-activity by components in extracts of Viscum album. Int J Immunopharmacol (1987) 0.79
Preservation of cytotoxic function during multi-cycle immunomagnetic cell separations of human NK cells using a new type of magnetic bead. J Immunol Methods (1990) 0.79
Structure and immunogenic behaviour of methylated tobacco mosaic virus. Biochim Biophys Acta (1976) 0.79
Monoclonal antibodies produced by in vitro immunization with sera of human-xenotransplant-bearing mice. Immunol Lett (1988) 0.79
Induction of labour with intravaginal misoprostol in the second and third trimesters of pregnancy. S Afr Med J (1995) 0.79
Chemical modification and immunogenicity of membrane fractions from mouse tumour cells. Br J Cancer (1978) 0.79
Plastidic trnFUUC pseudogenes in North American genus Boechera (Brassicaceae): mechanistic aspects of evolution. Plant Biol (Stuttg) (2007) 0.79
An approach to the routine estimation of circulating carcinoembryonic antigen immune complexes in patients with carcinomata of the gastrointestinal tract. Clin Exp Immunol (1979) 0.79
Prognostic value of preoperative serum CEA level compared to clinical staging. IV. Histological grading and tumor type in colorectal and gastric cancer. J Surg Oncol (1986) 0.79
Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer. Biomedicine (1980) 0.78
Observation on the capping of spleen lymphocytes from scrapie infected mice after treatment with anti Ig. Med Microbiol Immunol (1981) 0.78
The disulfide linkages in kallikrein inactivator of bovine lung. J Biol Chem (1966) 0.78
Otitis media in early childhood and cognitive, academic, and classroom performance of the school-aged child. Pediatrics (1989) 0.78
Highly specific characterization of tyrosine phosphoproteins in tumor cells based on monoclonal antibodies defined by conjugated phosphotyramine. Anticancer Res (1990) 0.78
[Computer-supported postoperative CEA-course controls : correlation with the prognosis of recurrence and findings of second-look operations]. Z Gastroenterol Verh (1976) 0.78